COPANLISIB AND VOLASERTIB OVERCOME IBRUTINIB‐VENETOCLAX RESISTANCE VIA TARGETING PI3K‐AKT SIGNALING AND G2/M CELL CYCLE TRANSITION IN MANTLE CELL LYMPHOMA
Zhang, R., Lee, W., Huang, S., Liu, Y., Leeming, A.H., McIntosh, J.M., Nomie, K.J., Jiang, C.V., Wang, M.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article